{"name":"ABX advanced biochemical compounds GmbH","slug":"abx-advanced-biochemical-compounds-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"F-18-PSMA-1007","genericName":"F-18-PSMA-1007","slug":"f-18-psma-1007","indication":"PET imaging of PSMA-positive lesions in prostate cancer patients","status":"phase_3"},{"name":"F-18-Fluorocholine","genericName":"F-18-Fluorocholine","slug":"f-18-fluorocholine","indication":"PET imaging of prostate cancer","status":"phase_3"}]}],"pipeline":[{"name":"F-18-PSMA-1007","genericName":"F-18-PSMA-1007","slug":"f-18-psma-1007","phase":"phase_3","mechanism":"F-18-PSMA-1007 is a fluorine-18 labeled small molecule that binds to prostate-specific membrane antigen (PSMA) for positron emission tomography (PET) imaging of PSMA-expressing tumors.","indications":["PET imaging of PSMA-positive lesions in prostate cancer patients","Detection and staging of metastatic prostate cancer"],"catalyst":""},{"name":"F-18-Fluorocholine","genericName":"F-18-Fluorocholine","slug":"f-18-fluorocholine","phase":"phase_3","mechanism":"F-18-Fluorocholine is a positron emission tomography (PET) imaging agent that accumulates in cells with high choline metabolism, enabling visualization of metabolically active tissues.","indications":["PET imaging of prostate cancer","PET imaging of brain tumors","PET imaging of other malignancies with elevated choline metabolism"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNeFYxTWlKUWZKY1d5cXlNejBFVWs2cmhQU0xlYU5sOEw3d1RDZlNURHFtTVZYTXBYUmZJRGpVa1Uyd3d2MWNpdXp6RWVKZHdMcG9LM2ZNS0FzMTc1SDFqMkZWMUxmRkdaZVI4dmxNaklTczlvcmQ1dGZrQUUtM2FQdlctMGdjZGhjN1ZqcVN2R0hzbTZBWEh4aHhhRFpoVFFsUWRUcVhBd3Nkam9wTnUtWQ?oc=5","date":"2025-09-01","type":"pipeline","source":"VC Magazin","summary":"New cluster strengthens Saxony’s position in the life sciences sector - VC Magazin","headline":"New cluster strengthens Saxony’s position in the life sciences sector","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxQcDhuRXZxemVuUzJ5a1VxWEtuRmtPSFRpSXZYa0Q4NTJGazhjRTFIX3plRDdXRWJWdjBWMHZockw3SXFvU3VpUEZoT2hSQjU4UTBBTTJOTVlEN2dSSE01STFyTVRuc1p3MGhac1djNkM0WXowZEFuMm54QlI0LUtBYVN3elczYlhsc1l3RUlMODh3a3AtWDlkQzlqd2JxeW1VSkdnd2VkT3RhaEhmbEV6ZnFTRzNFZjVMVHh2Y3lkZFE0aTlsdHBWd1NaSXYzaVByTEpFV040NFRXTG1hektHMVFn?oc=5","date":"2025-07-03","type":"pipeline","source":"BioSpace","summary":"Primo Biotechnology Secures A Funding and Targets 2026 IPO to Strengthen Global Radiopharmaceutical Strategy - BioSpace","headline":"Primo Biotechnology Secures A Funding and Targets 2026 IPO to Strengthen Global Radiopharmaceutical Strategy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxOOXJNYnd4MlJlUWI0cWk4eDQ3Y0wzQlVZeURXTVhnazhTTUF3NTE4NEpfLURJUFdoVmlqc2FJX3YzZGFaSnR6cnN0OW5QclB4cDI1X2RBeTJiZHVTTEduamhUT1RlZGNlVDZSMzZGenF4blZNLW90Z3JRNTVicTNhNDVySVFLcXVZc2JfSzFFRzFZNWh5RHp3YXJQRDl5MzdZak9pNElpOW9iMkp2VnJpemtNUU1WYm9sRDh2RFVYa0sxMGtEQ1NJNlVKY2U5Rm5CZnBQVnRGbzgzRGdwY2ZRMkYzejUxdw?oc=5","date":"2025-03-19","type":"deal","source":"GlobeNewswire","summary":"Primo Partners with ABX to Bring PB01 Closer to Taiwan’s Prostate Cancer Market - GlobeNewswire","headline":"Primo Partners with ABX to Bring PB01 Closer to Taiwan’s Prostate Cancer Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOa0FkSGtFdXJDLUdOX29jOUZlNWxhVlRtSWNablF3LTUweWU3blhOTjJKdDRsbW92NjJvYkRnTTRQSkR0Y0FKOGROOVJLcjlTTkNnUjRwS21Zc2VDM2xiRGR5NkFOd3oySGpHbE9qbTg2eWJqbjdFcTlJS1BJWXJTeDVzWjQ3eTRrZ0ZjNGVNRV83dVJkVUFWMmN3?oc=5","date":"2024-03-22","type":"pipeline","source":"openPR.com","summary":"PET Radiotracer Market Size Will Expected to Reach USD 3.2 - openPR.com","headline":"PET Radiotracer Market Size Will Expected to Reach USD 3.2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNbnFrNU1VTWlUdS02emphXzRqVzRWLWVDVnZoTEZTMFRjR0tkaU1JTmJyZWNuUnN1WHRnaVRSRmkzMW85NF9lTkdrcWxtdkxuUEZwbTI4TzVjWC1nWVdLMzR6UkF4WXA4Zm9jclNBVGYwR0NZT3hhdHZCVHB1RjdzZ0xPa19pNkhKN3l1NE8tMTZ0ZVBvV3d0TkNhRlppcHpfdTdDS1ZRTWdRcGh3REVCc0dhUWFFWEFfUUdRblBmNnYtLXdl?oc=5","date":"2022-08-15","type":"pipeline","source":"emjreviews.com","summary":"Improvements in Prostate Cancer Management: Focus on Imaging and Treatment - emjreviews.com","headline":"Improvements in Prostate Cancer Management: Focus on Imaging and Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTFBMR2E2ZTJDU2ZsOEkzeHdMbmFOQ3AwRnBwRzgyTVdnZlptbDRwN1FKOTFZUmRxUEpHZ2NtUWJaVHZPQlQ1RGhZaEhESkIzSkJFbmdDQ3U5VQ?oc=5","date":"2021-02-01","type":"pipeline","source":"jnm.snmjournals.org","summary":"F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical Recurrence - jnm.snmjournals.org","headline":"F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical Recurrence","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}